Listing #6096941 oncnursingnews.com

323
The FDA granted a priority review for a Biologics License Application (BLA) to bastilimab for the treatment of recurrent or metastatic cervical cancer. Cancer ...

Category

Website Performance

observedLargestContentfulPaintAllFramesTs 443729478703
cumulativeLayoutShift 0 Sec
observedFirstVisualChange 0.7 Sec
interactive 7.11 Sec
maxPotentialFID 0.31 Sec
speedIndex 3.64 Sec
observedFirstContentfulPaintAllFrames 0.39 Sec
observedFirstContentfulPaint 0.39 Sec
observedLargestContentfulPaintTs 443729478703
observedFirstPaint 0.39 Sec
observedTimeOriginTs 443727920964
observedLastVisualChangeTs 443733832964
observedTraceEnd 9.03 Sec
observedDomContentLoaded 0.24 Sec
totalCumulativeLayoutShift 0 Sec
firstMeaningfulPaint 2.24 Sec
observedTraceEndTs 443736952993
observedFirstVisualChangeTs 443728615964
observedSpeedIndex 2.73 Sec
observedDomContentLoadedTs 443728156192
observedTotalCumulativeLayoutShift 0 Sec
observedLastVisualChange 5.91 Sec
largestContentfulPaint 4.41 Sec
observedFirstMeaningfulPaint 1.56 Sec
cumulativeLayoutShiftMainFrame 0 Sec
observedCumulativeLayoutShift 0 Sec
totalBlockingTime 0.68 Sec
observedLargestContentfulPaint 1.56 Sec
firstContentfulPaint 1.31 Sec
observedSpeedIndexTs 443730652731
observedFirstContentfulPaintTs 443728305806
observedLoadTs 443731688105
observedLargestContentfulPaintAllFrames 1.56 Sec
observedCumulativeLayoutShiftMainFrame 0 Sec
observedLoad 3.77 Sec
observedFirstMeaningfulPaintTs 443729478703
observedTimeOrigin 0 Sec
observedNavigationStartTs 443727920964
observedFirstContentfulPaintAllFramesTs 443728305806
observedNavigationStart 0 Sec
observedFirstPaintTs 443728305806